Archive for 'Health'

Debt Relief Can Improve Your Overall Health

Debt is a burden that millions of Americans carry on a daily basis. In fact, the average family spends 20 percent of their household income paying down debt. But the scary fact about debt is that it doesn’t just impact your finances.

No one knows the far-reaching impact of debt more than Sharon, a former client of the nonprofit organization, Money Management International (MMI). Sharon struggled for years to stay current on more than $40,000 of debt, but eventually found a solution for overcoming the financial burden that she had faced for so long. Sharon, as well as others in similar situations, share their experiences and their journey throughout the debt repayment process through MMI’s new podcast series.

“I’m just a normal everyday mom who goes to work and tries to raise my kids,” Sharon said. “At the end of the program I paid off $40,000 in debt. Paying off my debt felt unbelievable; I was as happy as I was the day my kids were born.”

The financial experts at MMI have found that stress caused by financial worries can be detrimental to your health. Your emotional and mental stability, as well as your personal and professional relationships, are all at risk when finances feel out of control.

“You have a job to do at work, but you still have to come home and perform there as well. Receiving the collection calls is embarrassing. Dealing with debt was a major distraction,” Sharon said. “I felt inadequate. I felt like I was failing.”

According to an MMI personal finance survey, 24 percent of Americans blame financial hardships for health-related issues such as depression, anxiety, and problems sleeping. Financial stress can also be linked to failed relationships. Twenty-seven percent of Americans feel their marriage is impacted the most by financial worries.

With such far-reaching impacts, tackling debt can feel like an overwhelming process, which Sharon described as “trying to dig out of a hole that I was never going to get out of.”

This is why MMI wants to make the process as easy as possible by offering consumers free debt and budget counseling. As the largest nonprofit credit counseling agency in the nation, MMI has helped consumers pay back more than $740 million in debt in 2010 alone. Because we know that getting out of debt does more than improve finances – – it improves lives.

“My outlook on life has really changed,” Sharon said. “My confidence is through the roof. I feel like I can do anything. I’m not bound by credit and debt.”

About Money Management International
Money Management International (MMI) is a nonprofit, full-service credit-counseling agency, providing confidential financial guidance, financial education, counseling and debt management assistance to consumers since 1958. MMI helps consumers trim their expenses, develop a spending plan and repay debts. Counseling is available by appointment in branch offices and 24/7 by telephone and Internet. Services are available in English or Spanish. To learn more, call 800.432.7310 or visit

Let’s keep in touch!

Visit us on the Web at

Weight Watchers International, Inc. (NYSE: WTW) today announced that its Board of Directors declared its quarterly cash dividend of $0.175 per share of common stock, which corresponds to an annual dividend rate of $0.70 per share.  This quarterly dividend will be payable on October 14, 2011 to shareholders of record at the close of business on September 30, 2011.

About Weight Watchers International, Inc.

Weight Watchers International, Inc. is the world’s leading provider of weight management services, operating globally through a network of Company-owned and franchise operations. Weight Watchers holds over 45,000 meetings each week where members receive group support and learn about healthy eating patterns, behavior modification and physical activity. provides innovative, subscription weight management products over the Internet and is the leading Internet-based weight management provider in the world. In addition, Weight Watchers offers a wide range of products, publications and programs for those interested in weight loss and weight control.

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations and beliefs, as well as a number of assumptions concerning future events. These statements are subject to risks, uncertainties, assumptions and other important factors. Readers are cautioned not to put undue reliance on such forward-looking statements because actual results may vary materially from those expressed or implied. The reports filed by the Company pursuant to United States securities laws contain discussions of these risks and uncertainties. The Company assumes no obligation to, and expressly disclaims any obligation to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers are advised to review the Company’s filings with the United States Securities and Exchange Commission (which are available from the SEC’s EDGAR database at, at various SEC reference facilities in the United States and via the Company’s website at ).

Contact Information:
Weight Watchers International, Inc. Brainerd Communicators, Inc.
Sarika Sahni Corey Kinger
Investor Relations (212) 986-6667
(212) 589-2751

Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced that it will not  proceed with the proposed acquisition comprising the business and assets of Plasvacc Holdings Limited (Plasvacc) as previously announced on July 4, 2011. The parties have failed to reach agreement on definitive transaction documents and have terminated discussions under their letter of intent in connection with the transaction.

“We are disappointed that we could not successfully conclude this acquisition,” said Graeme McRae, Chairman, President & CEO of Bioniche Life Sciences Inc. “However, this outcome does not affect our intentions to selectively acquire rights to commercially-important animal health products and technologies, one of the stated uses of proceeds for our C$28.9 million concurrent financings in Canada and Australia completed earlier this year. A number of other potential acquisitions are currently under consideration.”

About Bioniche Life Sciences Inc.

Bioniche Life Sciences Inc. is a research-based, technology-driven Canadian biopharmaceutical company focused on the discovery, development, manufacturing, and marketing of proprietary products for human and animal health markets worldwide. The fully-integrated company employs more than 200 skilled personnel and has three operating divisions: Human Health, Animal Health, and Food Safety. The Company’s aims to develop and commercialize proprietary and innovative products for human and animal health.

The Animal Health division – Bioniche Animal Health – develops, manufactures and markets animal health biopharmaceutical products worldwide. It has product development, manufacturing and marketing facilities in Belleville, Ontario, Canada; marketing and production facilities in Athens, Georgia, U.S.A.; Pullman, Washington, U.S.A.; and Armidale, New South Wales, Australia. The Australian business is conducted from two sites: Melbourne, Victoria, where sales and marketing, customer support and technical service are located; and Armidale, New South Wales, where production (manufacturing facility, farm/research and development facility) is located.

Bioniche Life Sciences Inc. has been named one of the Top 50 Best Small and Medium-Sized Employers in Canada for 2010. For more information, please visit

Except for historical information, this news release may contain forward-looking statements that reflect the Company’s current expectation regarding future events. These forward-looking statements involve risk and uncertainties, which may cause, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process, and other risks detailed from time to time in the Company’s ongoing quarterly and annual reporting.


RegenoCELL Therapeutics, Inc. (OTCBB: RCLL) , a leader in adult stem cell therapy, is pleased to announce the opening of another state of the art facility in Greece for patients to be treated for congestive heart failure and peripheral artery disease with its autologous stem cell therapy.

The Company’s treatment for congestive heart failure is administered at the Metropolitan Hospital in Athens, which is part of the PERSEUS Heath Care Group.  Greece is a convenient location for patients living in Europe and offers patients an additional location where the company’s autologous stem cell treatments are permitted.

About RegenoCELL Therapeutics, Inc.

RegenoCELL Therapeutics, Inc. is a stem cell therapy company using adult stem cells for autologous treatment of patients.  The Company plans to obtain regulatory approval in the United States and the European Community to market its stem cell treatments.  Through its wholly owned foreign subsidiaries, the company is marketing its stem cell treatments for transplantation in jurisdictions where autologous therapy is permitted.

Cardiac Disease

There are therapies to treat congestive heart failure.  But there comes a treatment point when the only option may be a heart transplant.  Over 25,000 people are on the transplant lists but fewer than 2,500 receive one.  The mean life expectancy of a heart transplant recipient is 8 years. A new therapeutic approach to treat this disease is needed.

Peripheral Artery Disease

The same RCLL adult stem cell treatment can be used to treat peripheral artery disease. In the United States, there are over 10 million people suffering from the lack of sufficient blood flow to the extremities with an equal number in Europe. This disease is most often experienced by diabetics in their toes and lower legs.

Since 2005, the company’s stem cell therapy has successfully treated over 500 patients.  The typical patient is suffering from congestive heart failure with no treatment options and 3 to 6 months to live.  A half liter of blood is extracted from the patient and sent to the company’s subsidiary cell processing facility in Israel.  There the patient’s stem cells are extracted and grown from tens of thousands into many millions.  The stem cells are primed for angiogenesis or blood vessel formation.  The patient then travels to a jurisdiction where autologous therapy is permitted and has the stem cells transplanted in a hospital in a catherization laboratory in a procedure similar to angioplasty.

Forward-Looking Statements:

Except for historical matters contained herein, statements made in this press release are forward-looking and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  Without limiting the generality of the foregoing, words such as “may”, “will”, “to”, “plan”, “expect”, “believe”, “anticipate”, “intend”, “could”, “would”, “estimate”, or “continue” or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements.

Investors and others are cautioned that a variety of factors, including certain risks, may affect our business and cause actual results to differ materially from those set forth in the forward-looking statements.  These risk factors include, without limitation (i) our ability to obtain additional financing; (ii) our ability to control our expenses; (iii) our ability through our wholly owned foreign subsidiaries to manufacture and market our stem cell treatments; (iv) our ability to initiate and timely complete clinical trials; (v) the timing of and our ability to obtain and maintain regulatory approvals for our stem cell treatments; (vi) our dependence on the success of our lead stem cell treatment; (vii) our inability to predict the extent of our future losses or if or when we will become  profitable; (viii) our ability to protect our intellectual property rights; and, (ix) intense competition.  The Company is also subject to the risks and uncertainties described in our filings with the Securities and Exchange Commission, including the section entitled “Risk Factors” in its Annual Report on Form 10-K for the year ended December 31, 2010 and its Quarterly Report on ‘From 10-Q for the quarter ended March 31, 2011.

Contact: James Mongiardo, 508-647-4065,


How to Grow Medical Marijuana Legally

420 College - Helping Cannabis Economy Grow Legally
Two days and the cost of the seminar are a lot less then the price we’ve seen others pay for ignoring cultivation guidelines, or by following someone’s advice that’s mis-informed about the law.

420 College presents an intensive 2 Day LIVE EVENT on “How To Grow Legally”; for Collectives, Clubs, Delivery Services, Farmers, Cultivators; in the cool, high mountains of Lake Shasta – Redding, California , July 16th and 17th, Red Lion Inn. Register Online – $250 per Student , at the door.

“It’s not hard or as expensive to comply with the law as people think.” states 420 College Business Services Director, George Boyadjian. ” We focus on simple steps that a medical marijuana collective, delivery service or member farm need to take to get up and running, legally. We cover best practices for cultivation and testing, as well. Two days and the cost of the seminar are a lot less then the price we’ve seen others pay for ignoring cultivation guidelines, or by following someone’s advice that’s mis-informed about the law.”

Featured Speakers are medical marijuana industry experts with years of practical, hands-on expertise. Students will spend 2 days learning about how to start and run a successful, legal marijuana “farm”, club, collective or delivery service. We cover everything from new members and medical marijuana ID cards, marijuana patient/member rights, security, operations, authorization to cultivate, transport, testing, cultivation to harvest, processing and popular edibles.

Another treat is an invitation to a thriving farmer’s collective in Shasta Lake, CA. The Queen of Dragons will throw open their doors to 420 College students for a “wide-open” house to explore member activity areas, garden, meds room, edibles counter, trichomes imagery and testing while rubbing elbows with featured speakers and other like-minded collective member farmers and individuals.

$25 OFF Your Early Bird Registration – Sign Up by July 12 – Online at

420 College Live Events

From starting a medical marijuana business to educating on the subjects of compliance and cultivation, 420 College live events are designed to deliver guidance to beginners and current operators; providing step-by-step assistance in taking their next steps to becoming their collective’s legally operating member cultivator or farmer.

Contact: George Boyadjian – 323-308-8803 (cell) george(at)420college(dot)org

Since 2008, Tommy Lambert and his wife, Heather, have exclusively owned and operated Headhunters Lice Removal Service. Over the last 3 years, the company has treated numerous clients and provided an innovative, in demand service in the Atlanta, Georgia area. After experiencing a tremendous amount of growth and attaining a high level of success, the Lamberts have decided to further expand the company by offering a unique franchise opportunity to interested entrepreneurs.

The first company of its kind in the state of Georgia, Headhunters offers individuals the clean, professional environment of a salon in which they and their families can be comfortably treated for head lice. Not long ago, the Lamberts only offered in-home lice removal services; however, as the demand for their professional skills expanded, so have the services that they provide.

“With passion and family values, Headhunters is successful because we offer something that no other company does,” commented Tommy Lambert. “Many people are embarrassed when they find that their children have head lice. Bringing kids to our salon for lice removal is easier, more effective, and less stressful on parents than attempting to do it themselves. Over the counter products often fail, leaving parents frustrated and overwhelmed. For this reason, we offer our knowledge and provide our expertise, as we know our clients do not have time for lice.”

Now that the company has grown, the Lamberts are eager to take the next step in expansion. By offering franchised facilities, the Lamberts are allowing other entrepreneurs to benefit from their own hard work. The professionals that open franchised stores will utilize fresh networking and marketing strategies to contribute to the continued growth of the brand, benefiting both their own business aspirations and the company as a whole.

Professional lice removal services represent a developing trend in the business community. Due to the expertise of the professionals and the amount of stress their services detract from parents dealing with lice issues, many families are turning to Headhunters as their first line of defense against a lice infestation. Entrepreneurs who take advantage of the current franchising opportunity are likely to benefit from the growing popularity of the brand.

The current economy is on an upward swing, slowly healing from the recession. For business-minded individuals seeking new prospects, Headhunters is offering the opportunity to play a large role in the expansion and further development of an established and profitable brand.

“This franchise is really a wonderful chance for the right business professional to get involved with a great company,” stated Lambert. “After the last 3 years of development, we are confident in the brand and know that its potential growth will be a success, as long as it is expanded properly.”

Individuals interested in this exciting franchise opportunity should call 678-240-0042 or send an email to for more information. The company’s website, is also a valuable resource concerning information about this unique niche business.


Headhunters Lice Removal Service is a unique company that has put a modern spin on traditional head lice treatment. The first business of its kind in Georgia, Headhunters presents clients with the opportunity to be treated for lice in a salon environment. The company also offers school and camp screenings including on site treatments and in home lice removal service. With this diverse list of services aimed at containing and removing head lice, Headhunters has become the trusted lice removal resource in the Atlanta area.

Now looking to expand, Headhunters is offering entrepreneurs the chance to open their own branch of this successful company. For more information about Headhunters L.R.S., call 678-240-0042, visit or send an email to


Pet Insurance Company Sponsor's Cancer Research Walk

Pet Insurance Company Sponsor's Cancer Research Walk-Image via Wikipedia

Petplan pet insurance is dedicated to helping best friends live longer, healthier, cancer-free lives

Petplan, the world’s largest pet insurance provider, has become a national sponsor of Morris Animal Foundation’s K9 Cancer Walk program. As a national sponsor, the insurance company has pledged $8,000 to advance canine cancer research. The K9 Cancer Walk program was launched in 2008 to raise money for Morris Animal Foundation’s Canine Cancer Campaign, which helps dogs live longer, healthier, cancer-free lives.

“Our deep commitment to pet health is what drives us to provide pet parents with the most reliable, comprehensive pet health insurance protection available. For us, pets come first. That clear and singular focus is why we create fetch! pet health magazine four times a year, and what leads us to strong alliances with like-minded organizations, ” said Natasha Ashton, co-founder of Petplan. “Partnering with Morris Animal Foundation and their K9 Cancer Walk program is a way for us to join forces with a world leader in veterinary medicine, and together we will work to tackle canine cancer.”

Last year, Petplan partnered with Morris Animal Foundation to provide all K9 Cancer Walk participants with copies of fetch! magazine, Petplan’s prestigious publication.

“We are excited to expand our partnership with Petplan,” said Tish Czachor, Morris Animal Foundation’s canine cancer events manager. “Taking care of our pets is important, and we are excited that Petplan has joined in our fight against canine cancer.”

Registration is still open for this Saturday’s K9 Cancer Walk in Elk Grove, Calif.  Learn more about Morris Animal Foundation’s K9 Cancer Walk program at

About Morris Animal Foundation

Media Contact:
Tina M. Martinez, 800.243.2345 or 303.882.9376

New Natural Energy Drink Launched

Today Bonavitas launches a pilot program for fans to share and comment on Facebook about their experience with a new line of natural energy and recovery beverages.

Bonavitas natural products deliver the fuel one needs to get going in the morning, plus the vitamins, minerals and nutrients to replenish one’s body, support the organs and slow the aging process through a comprehensive approach to wellness with short-term energy and long-term recovery for one body. Sweet16 and Virgin Tequila are natural energy shots and R12 is a recovery drink that makes one feels better any time one is tired while improving one’s mood and replenishing the nutrients the body needs due to stress, work or old age.

“Nobody really has time to sit around and eat all the USDA-recommended fruits and vegetables every day. As a result, everybody is tired, stressed and poorly nourished”, said Jacques Jonassaint, CEO of Bonavitas.

Sweet16, Virgin Tequila and R12 can be purchased at the Bonavitas online store or from any member of our community. And, as our community of direct sellers, e-tailers, convenience stores and customers grows, Bonavitas will also make the natural energy and recovery beverages available through gyms, college campuses etc…

Bonavitas takes a fresh approach to direct sell by giving entrepreneurs the opportunity to earn income selling energy and recovery beverages through online social media, allowing members to tap into the power of the Internet. As we all aspire to be healthy and prosperous, Bonavitas offers everybody the opportunity to be wealthy and successful. Bonavitas uses the power of word-of-mouth advertising, social media marketing and personal relationships to get our energy and recovery beverages in the hands of the people who need and want them.

About Bonavitas
Headquartered in Provo, Utah, Bonavitas is a wellness company dedicated to the development and distribution of natural products that use science and natural ingredients for enhanced recovery, energy and overall health. Bonavitas chooses the nutrients and antioxidants that go into each product, based on scientifically supported benefits. Bonavitas offers a new approach to wellness – for everyone from elite athletes to moms on-the-go, weekend warriors and anyone with a pulse.

New products expand treatment options for healthcare providers

Boston Scientific Corporation (NYSE: BSX) today announced the acquisition of two novel technologies to treat peripheral chronic total occlusions (CTOs).  These acquisitions add technology platforms that complement the Company’s world-class portfolio of devices for lower extremity peripheral artery disease.

Boston Scientific acquired a re-entry catheter in November 2010 from S.I. Therapies, Ltd., based in Israel.  The Company will also acquire an intraluminal CTO crossing device through its acquisition of Sunnyvale, CA-based ReVascular Therapeutics, Inc., which is expected to close this month.  Worldwide launches of these devices in approved markets are planned later this year.

“Having used both devices, I am impressed with their simplicity and effectiveness,” said Dierk Scheinert, M.D., Heart Center Leipzig, and Professor of Medicine at the University of Leipzig.  “Access to these technologies will greatly enhance therapeutic options and provide physicians with new, intuitive solutions for treating challenging CTOs.”

A CTO, which represents a complete artery blockage, typically cannot be treated with standard endovascular devices such as guidewires and other catheter-based technologies.  CTO devices permit endovascular treatment in cases that otherwise might require a patient to undergo surgery or lower extremity amputation.  By offering both a re-entry and intraluminal crossing device, Boston Scientific will be well positioned to help physicians address the challenges of treating complex peripheral lesions.

“The purchase of these innovative CTO technologies demonstrates a continued commitment to expanding our peripheral interventions business,” said Joe Fitzgerald, Senior Vice President and President of Boston Scientific’s Endovascular Unit.  “Not only will they augment our products for treating patients with lower extremity peripheral artery disease, but they will strengthen our clinical relationships with customers by offering them additional ways to deliver patient care.”

“These acquisitions demonstrate our continued strategic execution of realigning and strengthening our portfolio in areas with high-growth potential,” said Ray Elliott, President and Chief Executive Officer of Boston Scientific.  “Our Priority Growth Initiatives include peripheral vascular disease, in which a significant number of patients remain undiagnosed or untreated.  Addressing these challenges through use of less-invasive devices could greatly improve the care these patients receive.”

Together, the transactions are expected to have an immaterial impact on GAAP and adjusted earnings in 2011 and 2012 and be accretive thereafter.  Transactional financial terms were not disclosed.

About Boston Scientific

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties.  For more information, please visit:

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.  Forward-looking statements may be identified by words like “anticipate,” “expect,” “project,” “believe,” “plan,” “estimate,” “intend” and similar words.  These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance.  These forward-looking statements include, among other things, statements regarding the market for peripheral vascular disease, impact of the acquisitions on financial performance, acquisition strategy, the timing and success of product launches and product performance.  If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements.  These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release.  As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; integration of acquired companies; closing of announced acquisitions and divestitures; financial market conditions; and future business decisions made by us and our competitors.  All of these factors are difficult or impossible to predict accurately and many of them are beyond our control.  For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A – Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A – Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file hereafter.  We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements.  This cautionary statement is applicable to all forward-looking statements contained in this document.

CONTACT: Erik Kopp
508-650-8660 (office)
Media Relations
Boston Scientific Corporation
Sean Wirtjes
508-652-5305 (office)
Investor Relations
Boston Scientific Corporation

When you have some free time, do you feel the urge to keep yourself busy and find something productive to do? If so, you are not alone. Even when they notice that their productivity is declining, some people are tempted to work even harder instead of taking a much needed break.

Our brains are like our bodies. Both need rest and relaxation to perform at their peak. If your brain doesn’t have a chance to recuperate, then your concentration decreases which later affects performance.

Now you know that rest and relaxation are important, but how do you fit them into a busy schedule? Here are some ideas to help.

Take five. Sometimes it just isn’t practical to take long periods of time off from your work. Sometimes, five minutes is all you need to give your mind the rest it deserves. Spend those five minutes doing whatever you want. Take deep breaths. Close your eyes. Go for a walk. It doesn’t matter, as long as you aren’t being productive in any way. If you have more time to spare, by all means, take it!

In the morning. It may be easier to find the time to rest and rejuvenate in the morning before your day begins. Set your alarm for fifteen minutes earlier than you usually do. Wake up and spend that time doing something quiet and relaxing. Sip coffee while watching the sunrise. Write in your journal. Go for a walk. Knit. Pick something that you enjoy doing and that usually leaves you feeling refreshed.

Before bed. You can also spend ten or fifteen minutes before bed doing something relaxing. Take a bath. Read. Do some stretches. Pick an activity that you enjoy and that puts your mind in a quiet. Avoid reading or television. Both activities can activate your brain and prevent you from getting a restful sleep.

Make time for exercise. Exercise helps your mind relax and releases stress toxins. Exercise can also increase your ability to focus and concentrate, making it easier for you to make the most of your time.

Do something fun. You’ve probably heard that “All work and no play makes Jack a dull boy.” It’s important to make time to do things you enjoy. It can be a hobby, or a walk in nature, or reading a good book. As long as you enjoy it, that’s all that matters.

Schedule it. If you are having trouble finding the time to rest and relax, try making an appointment in your schedule. Make an appointment with yourself to simply do something you enjoy and put it right on your calendar. Blocking out the time will make it seem more important and will also make it more likely that you actually take the time you need to rest and relax.

Looking to find the best time management advice, then visit to find the best time management tips.

 Page 1 of 2  1  2 »